We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
An image displaying a Newsletter on tablet, laptop & mobile

To continue reading this article, sign up for FREE to

Technology Networks logo


Membership is FREE and provides you with instant access to email newsletters, digital publications, our full content catalogue & more...

ChromaTrap™ Helps Advance Research into Women`s Reproductive Health

Read time: Less than a minute

An informative video interview with Professor Steve Conlan of the College of Medicine at Swansea University (UK) highlights the latest research developments in women’s reproductive health using unique molecular biology tools.

Developed by Prof Conlan in conjunction with Porvair Sciences, the Chromatrap solid state ChIP assay enables more tissue biopsies to be profiled for epigenetic landscape in less time and with greater efficiency than previously possible.

Prof Conlan explains the aims of his group’s work towards regenerative and personalized medicine therapies for the treatment of common gynaecological conditions such as ovarian and endometrial cancers and the role that the new Chromatrap ChIP assay tool has played in allowing faster progress in this research area.

A further video interview with Steve Knight of Porvair Sciences demonstrates the utility of the ChromaTrap solid state ChIP assay which enables high quality chromatin to be obtained from as few as 7000 cells in under five hours.

Laborious and error-prone liquid handling steps associated with traditional methods are eliminated with this novel filter-based kit.

Google News Preferred Source Add Technology Networks as a preferred Google source to see more of our trusted coverage.